Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Open Label, Phase III Trial Of CP- 751,871 In Combination With Paclitaxel And Carboplatin Versus Paclitaxel And Carboplatin In Patients With Non Small Cell Lung Cancer

NCT00596830 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00596830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00596830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Open Label, Phase III Trial Of CP- 751,871 In Combination With Paclitaxel And Carboplatin Versus Paclitaxel And Carboplatin In Patients With Non Small Cell Lung Cancer
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2008
Completion date
September 30, 2012
Enrollment
681 (actual)
Sites
280

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, adenosquamous, carcinoma, large cell, carcinoma, non-small-cell lung, carcinoma, squamous cell